Intensified cytarabine dose during consolidation in adult AML patients under 65 years is not associa...
Intensified cytarabine dose during consolidation in adult AML patients under 65 years is not associated with survival benefit: real-world data from the German SAL-AML registry
About this item
Full title
Author / Creator
Hanoun, Maher , Ruhnke, Leo , Kramer, Michael , Hanoun, Christine , Schäfer-Eckart, Kerstin , Steffen, Björn , Sauer, Tim , Krause, Stefan W. , Schliemann, Christoph , Mikesch, Jan-Henrik , Kaufmann, Martin , Hänel, Mathias , Jost, Edgar , Brümmendorf, Tim H. , Fransecky, Lars , Kraus, Sabrina , Einsele, Hermann , Niemann, Dirk , Neubauer, Andreas , Kullmer, Johannes , Seggewiss-Bernhard, Ruth , Görner, Martin , Held, Gerhard , Kaiser, Ulrich , Scholl, Sebastian , Hochhaus, Andreas , Reinhardt, H. Christian , Platzbecker, Uwe , Baldus, Claudia D. , Müller-Tidow, Carsten , Bornhäuser, Martin , Serve, Hubert , Röllig, Christoph and Study Alliance Leukemia (SAL)
Publisher
Berlin/Heidelberg: Springer Berlin Heidelberg
Journal title
Language
English
Formats
Publication information
Publisher
Berlin/Heidelberg: Springer Berlin Heidelberg
Subjects
More information
Scope and Contents
Contents
Purpose
Higher doses of cytarabine appear to improve long-term outcome in acute myeloid leukemia (AML), in particular for younger patients. To this end, the optimal dosage of single-agent cytarabine in consolidation therapy remains elusive. Here, we assessed the impact of different dosages of cytarabine consolidation after 7 + 3 induction on out...
Alternative Titles
Full title
Intensified cytarabine dose during consolidation in adult AML patients under 65 years is not associated with survival benefit: real-world data from the German SAL-AML registry
Authors, Artists and Contributors
Author / Creator
Ruhnke, Leo
Kramer, Michael
Hanoun, Christine
Schäfer-Eckart, Kerstin
Steffen, Björn
Sauer, Tim
Krause, Stefan W.
Schliemann, Christoph
Mikesch, Jan-Henrik
Kaufmann, Martin
Hänel, Mathias
Jost, Edgar
Brümmendorf, Tim H.
Fransecky, Lars
Kraus, Sabrina
Einsele, Hermann
Niemann, Dirk
Neubauer, Andreas
Kullmer, Johannes
Seggewiss-Bernhard, Ruth
Görner, Martin
Held, Gerhard
Kaiser, Ulrich
Scholl, Sebastian
Hochhaus, Andreas
Reinhardt, H. Christian
Platzbecker, Uwe
Baldus, Claudia D.
Müller-Tidow, Carsten
Bornhäuser, Martin
Serve, Hubert
Röllig, Christoph
Study Alliance Leukemia (SAL)
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_10349710
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_10349710
Other Identifiers
ISSN
0171-5216
E-ISSN
1432-1335
DOI
10.1007/s00432-022-04356-9
